Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers
Clinical trial NCT02670187 · COMPLETED
Trial details
- NCT number
- NCT02670187
- Sponsor
- GeneOne Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-05-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.